News
5mon
Medpage Today on MSNFDA Approves New Option for RosaceaParticipants were randomized to either daily minocycline hydrochloride (40 mg); doxycycline, the current standard of care; or ...
Emrosi â„¢ (minocycline hydrochloride extended-release capsules ... with significant improvement of rosacea compared with doxycycline 40mg and placebo, based on the proportion of patients who ...
Emrosi â„¢ (minocycline hydrochloride extended-release capsules ... treatment with Emrosi was associated with significant improvement of rosacea compared with doxycycline 40mg and placebo, based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results